Go to podcast
by The Cutaneous Connection
The Cutaneous Connection

Behind the Science of Molecular Targeting of Biologics


This episode highlights findings from an investigative study exploring the molecular targeting of biologics for psoriasis, as well as discusses the interleukin(IL)-17 class of biologics, how this class compares to other classes such as IL-23 and TNFα, and how bimekizumab sets itself apart from other biologics in the pipeline for psoriasis.


Episode 31

by The Cutaneous Connection